Prosecution Insights
Last updated: November 04, 2026
Application No. 16/656,585

SYSTEMS AND METHODS FOR MONITORING THE FUNCTIONALITY OF A BLOOD VESSEL

Non-Final OA §112
Filed
Oct 18, 2019
Priority
Oct 19, 2018 — provisional 62/748,185
Examiner
MOHAMMED, SHAHDEEP
Art Unit
3797
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Patensee Ltd.
OA Round
9 (Non-Final)
52%
Grant Probability
Moderate
9-10
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 52% of resolved cases
52%
Career Allowance Rate
251 granted / 485 resolved
-18.2% vs TC avg
Strong +57% interview lift
Without
With
+57.3%
Interview Lift
resolved cases with interview
Typical timeline
4y 5m
Avg Prosecution
35 currently pending
Career history
542
Total Applications
across all art units

Statute-Specific Performance

§101
8.9%
-31.1% vs TC avg
§103
39.6%
-0.4% vs TC avg
§102
9.1%
-30.9% vs TC avg
§112
36.1%
-3.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 485 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 09/03/2026 has been entered. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1-2, 4-5, 7-12, 15 and 18-27 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Regarding claims 1, the claim limitations “wherein said analyzing said at least one speckle image comprises detecting a change in a speckle pattern over time dur to movement in said VA” in lines 21-22 was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. The specification only recites speckle image in one paragraph (see par. [0166] of the Pg Pub. version of the specification), and par. [0166] discloses analyzing speckle image to detect pattern changes over time of red blood cells in blood vessels, but the speckle pattern changing over time is not related to movement in said VA. Claims 2, 4-5, 7-12, 15 and 21-27 are rejected as they depend from rejected claim 1. Regarding claim 18, the claim limitations “wherein said analyzing said at least one speckle image comprises detecting a change in a speckle pattern over time dur to movement in said patient’s fistula” in lines 16-17 was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. The specification only recites speckle image in one paragraph (see par. [0166] of the Pg Pub. version of the specification), and par. [0166] discloses analyzing speckle image to detect pattern changes over time of red blood cells in blood vessels, but the speckle pattern changing over time is not related to movement in said patient’s fistula. Claims 19 is rejected as they depend from rejected claim 18. Regarding claim 20, the claim limitations “wherein said analyzing said at least one speckle image comprises detecting a change in speckle pattern over time due to movement in said VA construct” in lines 23-24 was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. The specification only recites speckle image in one paragraph (see par. [0166] of the Pg Pub. version of the specification), and par. [0166] discloses analyzing speckle image to detect pattern changes over time of red blood cells in blood vessels, but the speckle pattern changing over time is not related to movement in said VA construct. Response to Arguments The previous clam rejection under 35 USC 112 (a) to claims 1, 18 and 20 has been withdrawn in view of Applicant’s amendments to the claims. Applicant’s arguments, filed on 09/03/2026, with respect to prior rejection(s) of claims 1, 18 and 20 have been fully considered and are persuasive. Therefore, the previous prior art rejection to claims 1, 18 and 20 has been withdrawn. However, upon further consideration and in view of Applicant’s amendments to claims 1, 18 and 20, a new ground(s) of rejection under 35 USC 112 (a) to claims 1, 18 and 20 is made Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Chong (US 10,869,623) discloses non-invasive optical measurement of blood analyte and speck imaging. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHAHDEEP MOHAMMED whose telephone number is (571)270-3134. The examiner can normally be reached Monday to Friday, 9am to 5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anne M Kozak can be reached at (571)270-0552. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SHAHDEEP MOHAMMED/ Primary Examiner, Art Unit 3797
Read full office action

Prosecution Timeline

Show 21 earlier events
Nov 19, 2025
Non-Final Rejection mailed — §112
Feb 19, 2026
Applicant Interview (Telephonic)
Feb 21, 2026
Examiner Interview Summary
Mar 18, 2026
Response Filed
Apr 08, 2026
Final Rejection mailed — §112
Sep 03, 2026
Request for Continued Examination
Sep 04, 2026
Response after Non-Final Action
Sep 23, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778686
AUTOMATED METHOD FOR DETERMINING THE SAFETY OF A STEREOTACTIC SURGICAL TRAJECTORY
4y 0m to grant Granted Nov 03, 2026
Patent 12765791
CROSS-DOMAIN UNROLLING-BASED IMAGING PHOTOPLETHYSMOGRAPHY SYSTEMS AND METHODS FOR ESTIMATING VITAL SIGNS
3y 1m to grant Granted Oct 20, 2026
Patent 12758452
ADVANCED MRI INCUBATOR HYBRID SYSTEM FOR SAFE INFANT IMAGING
1y 11m to grant Granted Oct 13, 2026
Patent 12751637
METHOD FOR DETERMINING A PHYSIOLOGICAL PARAMETER USING A PPG SIGNAL WITH REDUCED INFLUENCE OF VENOUS PULSATILITY
4y 11m to grant Granted Oct 06, 2026
Patent 12672853
METHOD AND PROBE FOR PREDICTING SPONTANEOUS PRETERM DELIVERY
2y 6m to grant Granted Jul 07, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

9-10
Expected OA Rounds
52%
Grant Probability
99%
With Interview (+57.3%)
4y 5m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 485 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month